Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Viscous Budesonide in Pediatric EoE
NCT00762073Phase 2Completed
- Sponsor
- Takeda
- Start
- Jan 2009
- Primary completion
- Apr 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of EPI-EE in eosinophilic esophagitis (EoE), sponsored by Takeda. Started Jan 2009; status: completed.
02
Drugs
EPI-EE
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NCT00762073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00762073.